Pure Global

A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients - Trial NCT06326879

Access comprehensive clinical trial information for NCT06326879 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Clinico Humanitas and is currently Recruiting. The study focuses on Colorectal Cancer. Target enrollment is 340 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06326879
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06326879
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients
Early-Onset Colorectal Cancer Versus Late-Onset Colorectal Cancer: a Prospective Observational Cohort Study to Explore the Clinical, Sociodemographic, Genetic, and Molecular Characteristics Associated With Adverse Oncological Outcomes (

Study Focus

Colorectal Cancer

No intervention

Observational

other

Sponsor & Location

Istituto Clinico Humanitas

Rozzano, Italy

Timeline & Enrollment

N/A

Nov 30, 2023

Oct 30, 2027

340 participants

Primary Outcome

Incidence rate ratio of colorectal cancer recurrence

Summary

This study aims to investigate the clinical, socioeconomic, behavioral, genetic, and
 molecular factors characterizing Early Onset Colorectal Cancer (EOCRC) patients compared with
 Late Onset Colorectal Cancer (LOCRC) patients

ICD-10 Classifications

Malignant neoplasm of colon
Malignant neoplasm: Descending colon
Malignant neoplasm: Colon, unspecified
Malignant neoplasm: Ascending colon
Malignant neoplasm: Overlapping lesion of colon

Data Source

ClinicalTrials.gov

NCT06326879

Non-Device Trial